Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Cyberattack on the European Medicines Agency 9 Prosinec 2020 News Corporate Joint strategy sets direction for EMA and EU medicines regulatory agencies to 2025 8 Prosinec 2020 News Human EMA website briefly unavailable on 3 December 2020 2 Prosinec 2020 News Corporate EMA starts rolling review of Janssen’s COVID-19 vaccine Ad26.COV2.S 1 Prosinec 2020 News Human COVID-19 Vaccines EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine 1 Prosinec 2020 News Human COVID-19 Vaccines EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2 1 Prosinec 2020 News Human COVID-19 Vaccines Global regulators urge continuation of COVID-19 vaccine trials for longer-term safety and efficacy follow-up 27 Listopad 2020 News Human COVID-19 Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 November 2020 27 Listopad 2020 News Human COVID-19 Pharmacovigilance Referrals Call for expressions of interest for Committee for Orphan Medicinal Products (COMP) members positions representing patient organisations 24 Listopad 2020 News Human Corporate Rare diseases Workshop on regulatory support for development of orphan medicines 23 Listopad 2020 News Human Early access Rare diseases Scientific advice 1 … 71 72 73 74 75 Page 75 of 380 76 77 78 79 … 380
Joint strategy sets direction for EMA and EU medicines regulatory agencies to 2025 8 Prosinec 2020 News Human
EMA starts rolling review of Janssen’s COVID-19 vaccine Ad26.COV2.S 1 Prosinec 2020 News Human COVID-19 Vaccines
EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine 1 Prosinec 2020 News Human COVID-19 Vaccines
EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2 1 Prosinec 2020 News Human COVID-19 Vaccines
Global regulators urge continuation of COVID-19 vaccine trials for longer-term safety and efficacy follow-up 27 Listopad 2020 News Human COVID-19 Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 November 2020 27 Listopad 2020 News Human COVID-19 Pharmacovigilance Referrals
Call for expressions of interest for Committee for Orphan Medicinal Products (COMP) members positions representing patient organisations 24 Listopad 2020 News Human Corporate Rare diseases
Workshop on regulatory support for development of orphan medicines 23 Listopad 2020 News Human Early access Rare diseases Scientific advice